Zenith Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Apr '26 Apr 29, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2018
Market Capitalization	701	1,230	1,075	-	-	-	Upgrade
Market Cap Growth	-52.50%	14.35%	-	-	-	-	Upgrade
Enterprise Value	1,214	1,389	1,332	-	-	-	Upgrade
Last Close Price	40.85	71.70	62.48	-	-	-	Upgrade
PE Ratio	18.57	17.17	11.27	-	-	-	Upgrade
PS Ratio	0.49	0.92	0.82	-	-	-	Upgrade
PB Ratio	0.98	1.77	1.73	-	-	-	Upgrade
P/TBV Ratio	1.01	1.78	1.73	-	-	-	Upgrade
EV/Sales Ratio	0.84	1.04	1.01	-	-	-	Upgrade
EV/EBITDA Ratio	8.92	9.79	7.38	-	-	-	Upgrade
EV/EBIT Ratio	14.65	12.38	7.96	-	-	-	Upgrade
Debt / Equity Ratio	0.72	0.70	0.39	1.47	1.55	1.73	Upgrade
Debt / EBITDA Ratio	3.81	3.43	1.33	2.64	2.75	2.20	Upgrade
Net Debt / Equity Ratio	0.72	0.70	0.24	1.46	1.31	1.52	Upgrade
Net Debt / EBITDA Ratio	3.78	3.41	0.84	2.61	2.31	1.94	Upgrade
Net Debt / FCF Ratio	-	-1.28	-0.72	-2.50	-177.62	-20.30	Upgrade
Asset Turnover	-	0.90	1.13	1.38	1.59	1.63	Upgrade
Inventory Turnover	-	2.68	3.47	4.38	7.67	9.34	Upgrade
Quick Ratio	0.75	0.77	1.19	0.69	0.75	0.84	Upgrade
Current Ratio	1.44	1.45	1.76	1.17	1.15	1.20	Upgrade
Return on Equity (ROE)	-	10.88%	23.86%	32.71%	29.71%	39.03%	Upgrade
Return on Assets (ROA)	-	4.74%	9.01%	6.46%	5.98%	8.05%	Upgrade
Return on Invested Capital (ROIC)	4.33%	8.89%	19.85%	17.64%	15.48%	19.39%	Upgrade
Return on Capital Employed (ROCE)	9.80%	13.60%	23.90%	32.70%	25.00%	35.10%	Upgrade
Earnings Yield	5.39%	5.82%	8.87%	-	-	-	Upgrade
FCF Yield	-	-30.56%	-19.69%	-	-	-	Upgrade
Dividend Yield	-	-	0.80%	-	-	-	Upgrade
Buyback Yield / Dilution	70.12%	-	-42.91%	-	-	-	Upgrade
Total Shareholder Return	70.12%	-	-42.11%	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.